Transduction for AAV with Sean Hart

Published on: 

Chris Spivey, editorial director, speaks with Sean Hart, CEO and SCO of LumaCyte, on percent transduction for AAV measured.

Chris Spivey, editorial director, speaks with Sean Hart, CEO and SCO of LumaCyte, on percent transduction for AAV measured. The full discussion can and more can be viewed here.

Related Content:

VaccinesDosage Forms
The Making of mRNA
Increasing mRNA Product Stability with Lyophilization
Navigating an Uncertain Regulatory Environment for mRNA-based Products